The coronavirus nucleocapsid is a multifunctional protein

Viruses

Volumn 6, Issue 8, 2014, Pages 2991-3018

  McBride, Ruth ^a   van Zyl, Marjorie ^a   Fielding, Burtram C ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Coronavirus assembly; Coronavirus N; Intracellular localization; Nucleocapsid protein; Protein topology

Indexed keywords

NUCLEOCAPSID PROTEIN; NUCLEOCAPSID PROTEIN, CORONAVIRUS;

CORONAVIRUS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIRUS REPLICATION;

CORONAVIRUS; NUCLEOCAPSID PROTEINS; PROTEIN TRANSPORT; VIRUS REPLICATION;

EID: 84905901545     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6082991     Document Type: Review

References (182)

1. Graham, R.L.; Donaldson, E.F.; Baric, R.S. A decade after SARS: Strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 2013, 11, 836-848.
2. Fielding, B.C. Human coronavirus NL63: A clinically important virus? Future Microbiol. 2011, 6, 153-159.
3. The International Committee for Taxonomy of Viruses (ICTV). Available online: htp://talk. ictvonline. org/files/ictv_documents/m/msl/4090. aspx (accessed on 27 June 2014).
4. Lai, M.M.; Cavanagh, D. The molecular biology of coronaviruses. Adv. Virus Res. 1997, 48, 1-100.
5. Pyrc, K.; Berkhout, B.; van der Hoek, L. The novel human coronaviruses NL63 and HKU1. J. Virol. 2007, 81, 3051-3057.
6. Fang, S.G.; Shen, H.; Wang, J.; Tay, F.P.; Liu, D.X. Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of Coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells. Virology 2008, 379, 175-180.
7. Brierley, I.; Boursnell, M.E.; Binns, M.M.; Bilimoria, B.; Blok, V.C.; Brown, T.D.; Inglis, S.C. An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J. 1987, 6, 3779-3785.
8. Snijder, E.J.; van der Meer, Y.; Zevenhoven-Dobbe, J.; Onderwater, J.J.; van der Meulen, J.; Koerten, H.K.; Mommaas, A.M. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 2006, 80, 5927-5940.
9. Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 439-450.
10. Snijder, E.J.; Bredenbeek, P.J.; Dobbe, J.C.; Thiel, V.; Ziebuhr, J.; Poon, L.L.; Guan, Y.; Rozanov, M.; Spaan, W.J.; Gorbalenya, A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 2003, 331, 991-1004.
11. Thiel, V.; Ivanov, K.A.; Putics, A.; Hertzig, T.; Schelle, B.; Bayer, S.; Weissbrich, B.; Snijder, E.J.; Rabenau, H.; Doerr, H.W.; et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 2003, 84 Pt 9, 2305-2315.
12. Laude, H.; Masters, P. The coronavirus nucleocapsid protein. In Coronaviruses and Arteriviruses; Plenum Press: New York, NY, USA, 1995; pp. 141-163.
13. Lai, M.; Cavanagh, D. The molecular biology of coronaviruses. Adv. Virus Res. 1997, 48, 1-100.
14. Masters, P. Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus. Arch. Virol. 1992, 125, 141-160.
15. Parker, M.M.; Masters, P.S. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology 1990, 179, 463-468.
16. Huang, Q.; Yu, L.; Petros, A.M.; Gunasekera, A.; Liu, Z.; Xu, N.; Hajduk, P.; Mack, J.; Fesik, S.W.; Olejniczak, E.T. Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry 2004, 43, 6059-6063.
17. Chang, C.K.; Sue, S.C.; Yu, T.H.; Hsieh, C.M.; Tsai, C.K.; Chiang, Y.C.; Lee, S.J.; Hsiao, H.H.; Wu, W.J.; Chang, C.F.; et al. The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcine respiratory and reproductive syndrome virus-like structure. FEBS Lett. 2005, 579, 5663-5668.
18. Keane, S.C.; Liu, P.; Leibowitz, J.L.; Giedroc, D.P. Functional transcriptional regulatory sequence (TRS) RNA binding and helix destabilizing determinants of murine hepatitis virus (MHV) nucleocapsid (N) protein. J. Biol. Chem. 2012, 287, 7063-7073.
19. Chang, C.K.; Hou, M.H.; Chang, C.F.; Hsiao, C.D.; Huang, T.H. The SARS coronavirus nucleocapsid protein-Forms and functions. Antivir. Res. 2014, 103C, 39-50.
20. Jayaram, H.; Fan, H.; Bowman, B.R.; Ooi, A.; Jayaram, J.; Collisson, E.W.; Lescar, J.; Prasad, B.V. X-ray structures of the N-and C-terminal domains of a coronavirus nucleocapsid protein: Implications for nucleocapsid formation. J. Virol. 2006, 80, 6612-6620.
21. Fan, H.; Ooi, A.; Tan, Y.W.; Wang, S.; Fang, S.; Liu, D.X.; Lescar, J. The nucleocapsid protein of coronavirus infectious bronchitis virus: Crystal structure of its N-terminal domain and multimerization properties. Structure 2005, 13, 1859-1868.
22. Spencer, K.A.; Hiscox, J.A. Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett. 2006, 580, 5993-5998.
23. Tan, Y.W.; Fang, S.; Fan, H.; Lescar, J.; Liu, D.X. Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res. 2006, 34, 4816-4825.
24. Oubridge, C.; Ito, N.; Evans, P.R.; Teo, C.H.; Nagai, K. Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature 1994, 372, 432-438.
25. Valegard, K.; Murray, J.B.; Stockley, P.G.; Stonehouse, N.J.; Liljas, L. Crystal structure of an RNA bacteriophage coat protein-operator complex. Nature 1994, 371, 623-626.
26. Grossoehme, N.E.; Li, L.; Keane, S.C.; Liu, P.; Dann, C.E., 3rd; Leibowitz, J.L.; Giedroc, D.P. Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. J. Mol. Biol. 2009, 394, 544-557.
27. Ma, Y.; Tong, X.; Xu, X.; Li, X.; Lou, Z.; Rao, Z. Structures of the N-and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus. Protein Cell 2010, 1, 688-697.
28. Sawicki, S.G.; Sawicki, D.L. A new model for coronavirus transcription. Adv. Exp. Med. Biol. 1998, 440, 215-219.
29. Zuniga, S.; Sola, I.; Alonso, S.; Enjuanes, L. Sequence motifs involved in the regulation of discontinuous coronavirus subgenomic RNA synthesis. J. Virol. 2004, 78, 980-994.
30. Zuniga, S.; Sola, I.; Moreno, J.L.; Sabella, P.; Plana-Duran, J.; Enjuanes, L. Coronavirus nucleocapsid protein is an RNA chaperone. Virology 2007, 357, 215-227.
31. Zuniga, S.; Cruz, J.L.; Sola, I.; Mateos-Gomez, P.A.; Palacio, L.; Enjuanes, L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J. Virol. 2010, 84, 2169-2175.
32. Urbaneja, M.A.; Wu, M.; Casas-Finet, J.R.; Karpel, R.L. HIV-1 nucleocapsid protein as a nucleic acid chaperone: Spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity. J. Mol. Biol. 2002, 318, 749-764.
33. Monaghan, A.; Webster, A.; Hay, R.T. Adenovirus DNA binding protein: Helix destabilising properties. Nucleic Acids Res. 1994, 22, 742-748.
34. Hurst, K.R.; Koetzner, C.A.; Masters, P.S. Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein. J. Virol. 2009, 83, 7221-7234.
35. You, J.; Dove, B.K.; Enjuanes, L.; DeDiego, M.L.; Alvarez, E.; Howell, G.; Heinen, P.; Zambon, M.; Hiscox, J.A. Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Gen. Virol. 2005, 86 Pt 12, 3303-3310.
36. Stohlman, S.A.; Baric, R.S.; Nelson, G.N.; Soe, L.H.; Welter, L.M.; Deans, R.J. Specific interaction between coronavirus leader RNA and nucleocapsid protein. J. Virol. 1988, 62, 4288-4295.
37. Chang, C.K.; Hsu, Y.L.; Chang, Y.H.; Chao, F.A.; Wu, M.C.; Huang, Y.S.; Hu, C.K.; Huang, T.H. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: Implications for ribonucleocapsid protein packaging. J. Virol. 2009, 83, 2255-2264.
38. Peng, T.Y.; Lee, K.R.; Tarn, W.Y. Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization. FEBS J. 2008, 275, 4152-4163.
39. Surjit, M.; Kumar, R.; Mishra, R.N.; Reddy, M.K.; Chow, V.T.; Lal, S.K. The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation. J. Virol. 2005, 79, 11476-11486.
40. Wu, C.H.; Yeh, S.H.; Tsay, Y.G.; Shieh, Y.H.; Kao, C.L.; Chen, Y.S.; Wang, S.H.; Kuo, T.J.; Chen, D.S.; Chen, P.J. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J. Biol. Chem. 2009, 284, 5229-5239.
41. Luo, H.; Chen, Q.; Chen, J.; Chen, K.; Shen, X.; Jiang, H. The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett. 2005, 579, 2623-2628.
42. Chang, C.K.; Sue, S.C.; Yu, T.H.; Hsieh, C.M.; Tsai, C.K.; Chiang, Y.C.; Lee, S.J.; Hsiao, H.H.; Wu, W.J.; Chang, W.L.; et al. Modular organization of SARS coronavirus nucleocapsid protein. J. Biomed. Sci. 2006, 13, 59-72.
43. Nelson, G.W.; Stohlman, S.A.; Tahara, S.M. High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J. Gen. Virol. 2000, 81, 181-188.
44. He, R.; Dobie, F.; Ballantine, M.; Leeson, A.; Li, Y.; Bastien, N.; Cutts, T.; Andonov, A.; Cao, J.; Booth, T.F.; et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 2004, 316, 476-483.
45. Chang, C.K.; Chen, C.M.; Chiang, M.H.; Hsu, Y.L.; Huang, T.H. Transient oligomerization of the SARS-COV N protein-Implication for virus ribonucleoprotein packaging. PLoS One 2013, 8, e65045.
46. Luo, H.; Ye, F.; Chen, K.; Shen, X.; Jiang, H. SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry 2005, 44, 15351-15358.
47. Yu, I.M.; Oldham, M.L.; Zhang, J.; Chen, J. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona-and arteriviridae. J. Biol. Chem. 2006, 281, 17134-17139.
48. Dyson, H.J.; Wright, P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6, 197-208.
49. Wright, P.E.; Dyson, H.J. Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. J. Mol. Biol. 1999, 293, 321-331.
50. Verheije, M.H.; Hagemeijer, M.C.; Ulasli, M.; Reggiori, F.; Rottier, P.J.; Masters, P.S.; de Haan, C.A. The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes. J. Virol. 2010, 84, 11575-11579.
51. Keane, S.C.; Giedroc, D.P. Solution structure of mouse hepatitis virus (MHV) nsp3a and determinants of the interaction with MHV nucleocapsid (N) protein. J. Virol. 2013, 87, 3502-3515.
52. Hurst, K.R.; Ye, R.; Goebel, S.J.; Jayaraman, P.; Masters, P.S. An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA. J. Virol 2010, 84, 10276-10288.
53. Lo, Y.S.; Lin, S.Y.; Wang, S.M.; Wang, C.T.; Chiu, Y.L.; Huang, T.H.; Hou, M.H. Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein. FEBS Lett. 2013, 587, 120-127.
54. Yu, I.M.; Gustafson, C.L.; Diao, J.; Burgner, J.W., 2nd; Li, Z.; Zhang, J.; Chen, J. Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain. J. Biol. Chem. 2005, 280, 23280-23286.
55. Chen, C.Y.; Chang, C.K.; Chang, Y.W.; Sue, S.C.; Bai, H.I.; Riang, L.; Hsiao, C.D.; Huang, T.H. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J. Mol. Biol. 2007, 368, 1075-1086.
56. Surjit, M.; Liu, B.; Kumar, P.; Chow, V.T.; Lal, S.K. The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. Biochem. Biophys. Res. Commun. 2004, 317, 1030-1036.
57. Takeda, M.; Chang, C.K.; Ikeya, T.; Guntert, P.; Chang, Y.H.; Hsu, Y.L.; Huang, T.H.; Kainosho, M. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method. J. Mol. Biol. 2008, 380, 608-622.
58. Zlotnick, A. Theoretical aspects of virus capsid assembly. J. Mol. Recognit. 2005, 18, 479-490.
59. Hsieh, P.K.; Chang, S.C.; Huang, C.C.; Lee, T.T.; Hsiao, C.W.; Kou, Y.H.; Chen, I.Y.; Chang, C.K.; Huang, T.H.; Chang, M.F. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J. Virol. 2005, 79, 13848-13855.
60. Huang, Y.; Yang, Z.Y.; Kong, W.P.; Nabel, G.J. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: Implications for assembly and vaccine production. J. Virol. 2004, 78, 12557-12565.
61. Hurst, K.R.; Kuo, L.; Koetzner, C.A.; Ye, R.; Hsue, B.; Masters, P.S. A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein. J. Virol. 2005, 79, 13285-13297.
62. Dunker, A.K.; Garner, E.; Guilliot, S.; Romero, P.; Albrecht, K.; Hart, J.; Obradovic, Z.; Kissinger, C.; Villafranca, J.E. Protein disorder and the evolution of molecular recognition: Theory, predictions and observations. Pac. Symp. Biocomput. 1998, 473-484.
63. Garner, E.; Romero, P.; Dunker, A.K.; Brown, C.; Obradovic, Z. Predicting Binding Regions within Disordered Proteins. Genome Inform. Workshop Genome Inform. 1999, 10, 41-50.
64. Dunker, A.K.; Lawson, J.D.; Brown, C.J.; Williams, R.M.; Romero, P.; Oh, J.S.; Oldfield, C.J.; Campen, A.M.; Ratliff, C.M.; Hipps, K.W.; et al. Intrinsically disordered protein. J. Mol. Graph. Model. 2001, 19, 26-59.
65. Luo, H.; Chen, J.; Chen, K.; Shen, X.; Jiang, H. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: Self-association analysis and nucleic acid binding characterization. Biochemistry 2006, 45, 11827-11835.
66. He, R.; Leeson, A.; Ballantine, M.; Andonov, A.; Baker, L.; Dobie, F.; Li, Y.; Bastien, N.; Feldmann, H.; Strocher, U.; et al. Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. Virus Res. 2004, 105, 121-125.
67. Hiscox, J.A.; Wurm, T.; Wilson, L.; Britton, P.; Cavanagh, D.; Brooks, G. The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus. J. Virol. 2001, 75, 506-512.
68. Reed, M.L.; Dove, B.K.; Jackson, R.M.; Collins, R.; Brooks, G.; Hiscox, J.A. Delineation and modelling of a nucleolar retention signal in the coronavirus nucleocapsid protein. Traffic 2006, 7, 833-848.
69. Cawood, R.; Harrison, S.M.; Dove, B.K.; Reed, M.L.; Hiscox, J.A. Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle 2007, 6, 863-867.
70. Wurm, T.; Chen, H.; Hodgson, T.; Britton, P.; Brooks, G.; Hiscox, J.A. Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division. J. Virol. 2001, 75, 9345-9356.
71. Rowland, R.R.; Chauhan, V.; Fang, Y.; Pekosz, A.; Kerrigan, M.; Burton, M.D. Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: Absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J. Virol. 2005, 79, 11507-11512.
72. Chen, H.; Wurm, T.; Britton, P.; Brooks, G.; Hiscox, J.A. Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell. J. Virol. 2002, 76, 5233-5250.
73. Lai, F.W.; Stephenson, K.B.; Mahony, J.; Lichty, B.D. Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-kappaB activation. J. Virol. 2014, 88, 54-65.
74. Timani, K.A.; Liao, Q.; Ye, L.; Zeng, Y.; Liu, J.; Zheng, Y.; Yang, X.; Lingbao, K.; Gao, J.; Zhu, Y. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res. 2005, 114, 23-34.
75. Zhou, B.; Liu, J.; Wang, Q.; Liu, X.; Li, X.; Li, P.; Ma, Q.; Cao, C. The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha. J. Virol. 2008, 82, 6962-6971.
76. Marra, M.A.; Jones, S.J.; Astell, C.R.; Holt, R.A.; Brooks-Wilson, A.; Butterfield, Y.S.; Khattra, J.; Asano, J.K.; Barber, S.A.; Chan, S.Y.; et al. The Genome sequence of the SARS-associated coronavirus. Science 2003, 300, 1399-1404.
77. De Haan, C.A.; Rottier, P.J. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005, 64, 165-230.
78. Robbins, S.G.; Frana, M.F.; McGowan, J.J.; Boyle, J.F.; Holmes, K.V. RNA-binding proteins of coronavirus MHV: Detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay. Virology 1986, 150, 402-410.
79. Baric, R.S.; Nelson, G.W.; Fleming, J.O.; Deans, R.J.; Keck, J.G.; Casteel, N.; Stohlman, S.A. Interactions between coronavirus nucleocapsid protein and viral RNAs: Implications for viral transcription. J. Virol. 1988, 62, 4280-4287.
80. Narayanan, K.; Kim, K.H.; Makino, S. Characterization of N protein self-association in coronavirus ribonucleoprotein complexes. Virus Res. 2003, 98, 131-140.
81. Risco, C.; Antón, I.M.; Enjuanes, L.; Carrascosa, J.L. The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J. Virol. 1996, 70, 4773-4777.
82. Escors, D.; Ortego, J.; Laude, H.; Enjuanes, L. The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J. Virol. 2001, 75, 1312-1324.
83. Kuo, L.; Masters, P.S. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J. Virol. 2002, 76, 4987-4999.
84. Macneughton, M.R.; Davies, H.A. Ribonucleoprotein-like structures from coronavirus particles. J. Gen. Virol. 1978, 39, 545-549.
85. Chen, H.; Gill, A.; Dove, B.K.; Emmett, S.R.; Kemp, C.F.; Ritchie, M.A.; Dee, M.; Hiscox, J.A. Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance. J. Virol. 2005, 79, 1164-1179.
86. Davies, H.A.; Dourmashkin, R.R.; Macnaughton, M.R. Ribonucleoprotein of Avian Infectious Bronchitis Virus. J. Gen. Virol. 1981, 53, 67-74.
87. De Haan, C.A.; Kuo, L.; Masters, P.S.; Vennema, H.; Rottier, P.J. Coronavirus particle assembly: Primary structure requirements of the membrane protein. J. Virol. 1998, 72, 6838-6850.
88. De Haan, C.A.; Smeets, M.; Vernooij, F.; Vennema, H.; Rottier, P.J. Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J. Virol. 1999, 73, 7441-7452.
89. Simons, K.; Garoff, H. The budding mechanisms of enveloped animal viruses. J. Gen. Virol. 1980, 50, 1-21.
90. Lopez, S.; Yao, J.S.; Kuhn, R.J.; Strauss, E.G.; Strauss, J.H. Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J. Virol. 1994, 68, 1316-1323.
91. Suomalainen, M.; Liljestrom, P.; Garoff, H. Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J. Virol. 1992, 66, 4737-4747.
92. Sturman, L.S.; Holmes, K.V.; Behnke, J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 1980, 33, 449-462.
93. Narayanan, K.; Maeda, A.; Maeda, J.; Makino, S. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J. Virol. 2000, 74, 8127-8134.
94. Stephens, E.B.; Compans, R.W. Assembly of animal viruses at cellular membranes. Annu. Rev. Microbiol. 1988, 42, 489-516.
95. Pettersson, R.F. Protein localization and virus assembly at intracellular membranes. Curr. Top. Microbiol. Immunol. 1991, 170, 67-106.
96. Tooze, J.; Tooze, S.; Warren, G. Replication of coronavirus MHV-A59 in sac-cells: Determination of the first site of budding of progeny virions. Eur. J. Cell Biol. 1984, 33, 281-293.
97. Fosmire, J.A.; Hwang, K.; Makino, S. Identification and characterization of a coronavirus packaging signal. J. Virol. 1992, 66, 3522-3530.
98. Van der Most, R.G.; Bredenbeek, P.J.; Spaan, W.J. A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 1991, 65, 3219-3226.
99. Woo, K.; Joo, M.; Narayanan, K.; Kim, K.H.; Makino, S. Murine coronavirus packaging signal confers packaging to nonviral RNA. J. Virol. 1997, 71, 824-827.
100. Narayanan, K.; Chen, C.J.; Maeda, J.; Makino, S. Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J. Virol. 2003, 77, 2922-2927.
101. Rota, P.A.; Oberste, M.S.; Monroe, S.S.; Nix, W.A.; Campagnoli, R.; Icenogle, J.P.; Penaranda, S.; Bankamp, B.; Maher, K.; Chen, M.H.; Tong, S.; et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300, 1394-1399.
102. Luo, Y.; Batalao, A.; Zhou, H.; Zhu, L. Mammalian two-hybrid system: A complementary approach to the yeast two-hybrid system. BioTechniques 1997, 22, 350-352.
103. Klumperman, J.; Locker, J.K.; Meijer, A.; Horzinek, M.C.; Geuze, H.J.; Rottier, P.J. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J. Virol 1994, 68, 6523-6534.
104. Vennema, H.; Godeke, G.J.; Rossen, J.W.; Voorhout, W.F.; Horzinek, M.C.; Opstelten, D.J.; Rottier, P.J. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 1996, 15, 2020-2028.
105. Corse, E.; Machamer, C.E. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J. Virol. 2000, 74, 4319-4326.
106. Boursnell, M.E.; Binns, M.M.; Brown, T.D. Sequencing of coronavirus IBV genomic RNA: Three open reading frames in the 5' 'unique' region of mRNA D. J. Gen. Virol. 1985, 66, 2253-2258.
107. Baudoux, P.; Carrat, C.; Besnardeau, L.; Charley, B.; Laude, H. Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes. J. Virol. 1998, 72, 8636-8643.
108. Ruch, T.R.; Machamer, C.E. The coronavirus E protein: Assembly and beyond. Viruses 2012, 4, 363-382.
109. Boscarino, J.A.; Logan, H.L.; Lacny, J.J.; Gallagher, T.M. Envelope protein palmitoylations are crucial for murine coronavirus assembly. J. Virol. 2008, 82, 2989-2999.
110. Siu, Y.L.; Teoh, K.T.; Lo, J.; Chan, C.M.; Kien, F.; Escriou, N.; Tsao, S.W.; Nicholls, J.M.; Altmeyer, R.; Peiris, J.S.; et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 2008, 82, 11318-11330.
111. Ruch, T.R.; Machamer, C.E. The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus. J. Virol. 2011, 85, 675-685.
112. Cologna, R.; Hogue, B.G. Coronavirus nucleocapsid protein. RNA interactions. Adv. Exp. Med. Biol. 1998, 440, 355-359.
113. Brayton, P.R.; Lai, M.M.; Patton, C.D.; Stohlman, S.A. Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J. Virol. 1982, 42, 847-853.
114. Spaan, W.J.; Rottier, P.J.; Horzinek, M.C.; van der Zeijst, B.A. Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology 1981, 108, 424-434.
115. Almazan, F.; Galan, C.; Enjuanes, L. The nucleoprotein is required for efficient coronavirus genome replication. J. Virol. 2004, 78, 12683-12688.
116. Schelle, B.; Karl, N.; Ludewig, B.; Siddell, S.G.; Thiel, V. Selective replication of coronavirus genomes that express nucleocapsid protein. J. Virol. 2005, 79, 6620-6630.
117. Thiel, V.; Herold, J.; Schelle, B.; Siddell, S.G. Viral replicase gene products suffice for coronavirus discontinuous transcription. J. Virol. 2001, 75, 6676-6681.
118. Casais, R.; Thiel, V.; Siddell, S.G.; Cavanagh, D.; Britton, P. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 2001, 75, 12359-12369.
119. Yount, B.; Denison, M.R.; Weiss, S.R.; Baric, R.S. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 2002, 76, 11065-11078.
120. Yount, B.; Curtis, K.M.; Baric, R.S. Strategy for systematic assembly of large RNA and DNA genomes: Transmissible gastroenteritis virus model. J. Virol. 2000, 74, 10600-10611.
121. Yount, B.; Curtis, K.M.; Fritz, E.A.; Hensley, L.E.; Jahrling, P.B.; Prentice, E.; Denison, M.R.; Geisbert, T.W.; Baric, R.S. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 2003, 100, 12995-3000.
122. Denison, M.R.; Spaan, W.J.; van der Meer, Y.; Gibson, C.A.; Sims, A.C.; Prentice, E.; Lu, X.T. The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis. J. Virol. 1999, 73, 6862-6871.
123. Sims, A.C.; Ostermann, J.; Denison, M.R. Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes. J. Virol. 2000, 74, 5647-5654.
124. Stertz, S.; Reichelt, M.; Spiegel, M.; Kuri, T.; Martinez-Sobrido, L.; Garcia-Sastre, A.; Weber, F.; Kochs, G. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 2007, 361, 304-315.
125. Van der Meer, Y.; Snijder, E.J.; Dobbe, J.C.; Schleich, S.; Denison, M.R.; Spaan, W.J.; Locker, J.K. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J. Virol. 1999, 73, 7641-7657.
126. Masters, P.S.; Koetzner, C.A.; Kerr, C.A.; Heo, Y. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 1994, 68, 328-337.
127. Hurst, K.R.; Koetzner, C.A.; Masters, P.S. Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex. J. Virol. 2013, 87, 9159-9172.
128. Sawicki, S.G.; Sawicki, D.L.; Siddell, S.G. A contemporary view of coronavirus transcription. J. Virol. 2007, 81, 20-29.
129. Zust, R.; Miller, T.B.; Goebel, S.J.; Thiel, V.; Masters, P.S. Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome. J. Virol. 2008, 82, 1214-1228.
130. Graham, R.L.; Denison, M.R. Replication of murine hepatitis virus is regulated by papain-like proteinase 1 processing of nonstructural proteins 1, 2, and 3. J. Virol. 2006, 80, 11610-11620.
131. Cristofari, G.; Darlix, J.L. The ubiquitous nature of RNA chaperone proteins. Prog. Nucleic Acid Res. Mol. Biol. 2002, 72, 223-268.
132. Herschlag, D. RNA chaperones and the RNA folding problem. J. Biol. Chem. 1995, 270, 20871-20874.
133. Chen, C.J.; Sugiyama, K.; Kubo, H.; Huang, C.; Makino, S. Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J. Virol. 2004, 78, 10410-10419.
134. Chen, C.J.; Makino, S. Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J. Virol. 2004, 78, 5658-5669.
135. Ikeda, K.; Monden, T.; Kanoh, T.; Tsujie, M.; Izawa, H.; Haba, A.; Ohnishi, T.; Sekimoto, M.; Tomita, N.; Shiozaki, H.; et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J. Histochem. Cytochem. 1998, 46, 397-403.
136. Hobbs, W.E., 2nd; DeLuca, N.A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 1999, 73, 8245-8255.
137. Lomonte, P.; Everett, R.D. Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. J. Virol. 1999, 73, 9456-9467.
138. Wiebusch, L.; Hagemeier, C. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J. Virol. 1999, 73, 9274-9283.
139. Lu, M.; Shenk, T. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J. Virol. 1999, 73, 676-683.
140. Cayrol, C.; Flemington, E.K. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 1996, 15, 2748-2759.
141. Xu, L.H.; Huang, M.; Fang, S.G.; Liu, D.X. Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase delta. J. Biol. Chem. 2011, 286, 39546-39559.
142. Surjit, M.; Liu, B.; Chow, V.T.; Lal, S.K. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J. Biol. Chem. 2006, 281, 10669-10681.
143. Kedersha, N.; Anderson, P. Stress granules: Sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans. 2002, 30, 963-969.
144. Shieh, Y.C.; Baric, R.S.; Woods, J.W.; Calci, K.R. Molecular surveillance of enterovirus and norwalk-like virus in oysters relocated to a municipal-sewage-impacted gulf estuary. Appl. Environ. Microbiol. 2003, 69, 7130-7136.
145. Raaben, M.; Groot Koerkamp, M.J.; Rottier, P.J.; de Haan, C.A. Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell. Microbiol. 2007, 9, 2218-2229.
146. Dalton, K.; Casais, R.; Shaw, K.; Stirrups, K.; Evans, S.; Britton, P.; Brown, T.D.; Cavanagh, D. cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J. Virol. 2001, 75, 125-133.
147. Hollfelder, F.; Herschlag, D. The nature of the transition state for enzyme-catalyzed phosphoryl transfer. Hydrolysis of O-aryl phosphorothioates by alkaline phosphatase. Biochemistry 1995, 34, 12255-12264.
148. Wang, Y.; Zhang, X. The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo. Virology 1999, 265, 96-109.
149. Menendez, A.; Chow, K.C.; Pan, O.C.; Scott, J.K. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope. J. Mol. Biol. 2004, 338, 311-327.
150. Gross, S.R.; Kinzy, T.G. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat. Struct. Mol. Biol. 2005, 12, 772-778.
151. Kurasawa, Y.; Watanabe, Y.; Numata, O. Characterization of F-actin bundling activity of Tetrahymena elongation factor 1 alpha investigated with rabbit skeletal muscle actin. Zool. Sci. 1996, 13, 371-375.
152. Numata, O.; Gonda, K.; Watanabe, A.; Kurasawa, Y. Cytokinesis in Tetrahymena: Determination of division plane and organization of contractile ring. Microsc. Res. Tech. 2000, 49, 127-135.
153. Chow, K.C.; Hsiao, C.H.; Lin, T.Y.; Chen, C.L.; Chiou, S.H. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am. J. Clin. Pathol. 2004, 121, 574-580.
154. Gu, J.; Gong, E.; Zhang, B.; Zheng, J.; Gao, Z.; Zhong, Y.; Zou, W.; Zhan, J.; Wang, S.; Xie, Z.; et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005, 202, 415-424.
155. Surjit, M.; Liu, B.; Jameel, S.; Chow, V.T.; Lal, S.K. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem. J. 2004, 383, 13-18.
156. Nakanaga, K.; Yamanouchi, K.; Fujiwara, K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J. Virol. 1986, 59, 168-171.
157. Spiegel, M.; Pichlmair, A.; Martinez-Sobrido, L.; Cros, J.; Garcia-Sastre, A.; Haller, O.; Weber, F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol 2005, 79, 2079-2086.
158. Kopecky-Bromberg, S.A.; Martinez-Sobrido, L.; Frieman, M.; Baric, R.A.; Palese, P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007, 81, 548-557.
159. Lu, X.; Pan, J.; Tao, J.; Guo, D. SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 2011, 42, 37-45.
160. Fang, S.; Xu, L.; Huang, M.; Qisheng Li, F.; Liu, D.X. Identification of two ATR-dependent phosphorylation sites on coronavirus nucleocapsid protein with nonessential functions in viral replication and infectivity in cultured cells. Virology 2013, 444, 225-232.
161. Jayaram, J.; Youn, S.; Collisson, E.W. The virion N protein of infectious bronchitis virus is more phosphorylated than the N protein from infected cell lysates. Virology 2005, 339, 127-135.
162. Yan, X.; Hao, Q.; Mu, Y.; Timani, K.A.; Ye, L.; Zhu, Y.; Wu, J. Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int. J. Biochem. Cell Biol. 2006, 38, 1417-1428.
163. He, R.; Leeson, A.; Andonov, A.; Li, Y.; Bastien, N.; Cao, J.; Osiowy, C.; Dobie, F.; Cutts, T.; Ballantine, M.; et al. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem. Biophys. Res. Commun. 2003, 311, 870-876.
164. Berry, M.; Manasse, T.-L.; Tan, Y.J.; Fielding, B.C. Characterisation of human coronavirus-NL63 nucleocapsid protein. Afr. J. Biotechnol. 2012, 11, 13962-13968.
165. Surjit, M.; Lal, S.K. The SARS-CoV nucleocapsid protein: A protein with multifarious activities. Infect. Genet. Evol. 2008, 8, 397-405.
166. Masters, P.S.; Sturman, L.S. Background paper. Functions of the coronavirus nucleocapsid protein. Adv. Exp. Med. Biol 1990, 276, 235-238.
167. Nguyen, V.P.; Hogue, B.G. Protein interactions during coronavirus assembly. J. Virol. 1997, 71, 9278-9284.
168. Opstelten, D.J.; Raamsman, M.J.; Wolfs, K.; Horzinek, M.C.; Rottier, P.J. Envelope glycoprotein interactions in coronavirus assembly. J. Cell Biol. 1995, 131, 339-349.
169. Rowles, D.L.; Terhune, S.S.; Cristea, I.M. Discovery of host-viral protein complexes during infection. Methods Mol. Biol. 2013, 1064, 43-70.
170. Luo, C.; Luo, H.; Zheng, S.; Gui, C.; Yue, L.; Yu, C.; Sun, T.; He, P.; Chen, J.; Shen, J.; et al. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem. Biophys. Res. Commun. 2004, 321, 557-565.
171. Wang, Q.; Li, C.; Zhang, Q.; Wang, T.; Li, J.; Guan, W.; Yu, J.; Liang, M.; Li, D. Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42. Virol. J. 2010, 7, 99.
172. Lv, M.; Chen, J.; Shi, H.; Chen, X.; Fan, X.; Shen, S.; Feng, L. Co-localization analysis between porcine epidemic diarrhea virus nucleocapsid protein and nucleolar phosphoprotein B23.1. Wei Sheng Wu Xue Bao 2011, 51, 643-647.
173. Zeng, Y.; Ye, L.; Zhu, S.; Zheng, H.; Zhao, P.; Cai, W.; Su, L.; She, Y.; Wu, Z. The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation. Biochem. Biophys. Res. Commun. 2008, 369, 287-291.
174. Zhao, X.; Nicholls, J.M.; Chen, Y.G. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J. Biol. Chem. 2008, 283, 3272-3280.
175. Zhang, Y.P.; Zhang, R.W.; Chang, W.S.; Wang, Y.Y. Cxcl16 interact with SARS-CoV N protein in and out cell. Virol. Sin. 2010, 25, 369-374.
176. Wei, W.Y.; Li, H.C.; Chen, C.Y.; Yang, C.H.; Lee, S.K.; Wang, C.W.; Ma, H.C.; Juang, Y.L.; Lo, S.Y. SARS-CoV nucleocapsid protein interacts with cellular pyruvate kinase protein and inhibits its activity. Arch. Virol. 2012, 157, 635-645.
177. Emmott, E.; Munday, D.; Bickerton, E.; Britton, P.; Rodgers, M.A.; Whitehouse, A.; Zhou, E.M.; Hiscox, J.A. The cellular interactome of the coronavirus infectious bronchitis virus nucleocapsid protein and functional implications for virus biology. J. Virol. 2013, 87, 9486-9500.
178. Meyniel-Schicklin, L.; de Chassey, B.; Andre, P.; Lotteau, V. Viruses and interactomes in translation. Mol. Cell. Proteomics 2012, 11, M111.014738, doi:10.1074/mcp.M111.014738.
179. Leung, D.T.; Tam, F.C.; Ma, C.H.; Chan, P.K.; Cheung, J.L.; Niu, H.; Tam, J.S.; Lim, P.L. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J. Infect. Dis. 2004, 190, 379-386.
180. Kim, T.W.; Lee, J.H.; Hung, C.F.; Peng, S.; Roden, R.; Wang, M.C.; Viscidi, R.; Tsai, Y.C.; He, L.; Chen, P.J.; et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J. Virol. 2004, 78, 4638-4645.
181. Buchholz, U.J.; Bukreyev, A.; Yang, L.; Lamirande, E.W.; Murphy, B.R.; Subbarao, K.; Collins, P.L. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. USA 2004, 101, 9804-9809.
182. Liang, F.Y.; Lin, L.C.; Ying, T.H.; Yao, C.W.; Tang, T.K.; Chen, Y.W.; Hou, M.H. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: Implications for the diagnosis of coronavirus infection. J. Virol. Methods 2013, 187, 413-420.